SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Siemens Healthineers AG SMMNY OTC

Other OTC • Healthcare • Medical - Devices • DE • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Siemens Healthineers AG (SMMNY) is a Medical - Devices company in the Healthcare sector, currently trading at $20.74. It has a SharesGrow Score of 63/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Financials: revenue is $22.0B, +0.5%/yr average growth. Net income is $2.0B, growing at +2.3%/yr. Net profit margin is 9.2% (thin). Gross margin is 38.6% (+1.1 pp trend).

Balance sheet: total debt is $17.7B against $21.2B equity (Debt-to-Equity (D/E) ratio 0.83, moderate). Current ratio is 1.11 (adequate). Debt-to-assets is 33.9%. Total assets: $52.1B.

Analyst outlook: 1 / 2 analysts rate SMMNY as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 45/100 (Partial), Past 100/100 (Pass), Health 67/100 (Partial), Moat 66/100 (Partial), Future 40/100 (Partial), Income 45/100 (Partial).

SMMNY SharesGrow Score Overview

63/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 75/100

Valuation — P/E, PEG, Forward PEG

GROWTH 45/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 66/100

Gross margin is + market cap

FUTURE 40/100

Analyst outlook — as buy

INCOME 45/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SMMNY

SMMNY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SMMNY: +0.5%/yr revenue is, +2.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SMMNY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SMMNY: Debt-to-Equity (D/E) ratio 0.83 (moderate), Current ratio is 1.11 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SMMNY: Gross margin is 38.6% (+1.1 pp trend), $93B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 66/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 2 analysts rate SMMNY as buy (50%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SMMNY: Net profit margin is 9.2%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range20.39-28.92

Avg Volume (30D)172.62K

Market Cap$93.39B

Beta (1Y)0.85

Dividend Yield$0.3673

Share Statistics

EPS (TTM)0.90

Shares Outstanding$2.24B

IPO Date2018-05-14

Employees72,000

CEOBernhard Montag

Financial Highlights & Ratios

Revenue (TTM)$22.03B

Gross Profit$8.51B

EBITDA$4.32B

Net Income$2.02B

Operating Income$3.24B

Total Cash$2.25B

Total Debt$17.7B

Net Debt$-1.42B

Total Assets$52.13B

Price / Earnings (P/E)23

Price / Sales (P/S)4.24

Analyst Forecast

Rating ConsensusBuy

Analysts Covering2

Buy 50% Hold 50% Sell 0%

Company Info

CountryDE

ExchangeOther OTC

CurrencyUSD

ISINUS82622J1043

Price Chart

SMMNY

Siemens Healthineers AG ↗ · Other OTC

Healthcare • Medical - Devices

20.39 52WK RANGE 28.92

People Also View

EssilorLuxottica S.A.

Chugai Pharmaceutical Co., Ltd.

HOYA Corporation

MERCK Kommanditgesellschaft auf Aktien

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message